Invesco Dynamic Biotechnology & Genome ETF
Price through Nov 16, 2026 · Flows through Nov 13, 2026. Figures use the latest available records, not a live quote. Fund details retrieved Nov 16, 2026. Holdings snapshot retrieved Nov 16, 2026.
The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying intellidex. The underlying intellidex was composed of common stocks of U.S. biotechnology and genome companies. These companies are engaged principally in the research, development, manufacture and marketing and distribution of various biotechnological products, services and processes, etc. It is non-diversified.
PBE price
Table
| Date | PBE close |
|---|---|
| Aug 17, 2026 | $94.72 |
| Aug 18, 2026 | $95.28 |
| Aug 19, 2026 | $98.26 |
| Aug 20, 2026 | $96.56 |
| Aug 21, 2026 | $97.59 |
| Aug 24, 2026 | $97.30 |
| Aug 25, 2026 | $98.73 |
| Aug 26, 2026 | $98.09 |
| Aug 27, 2026 | $98.54 |
| Aug 28, 2026 | $96.32 |
| Aug 31, 2026 | $96.68 |
| Sep 1, 2026 | $96.94 |
| Sep 2, 2026 | $98.68 |
| Sep 3, 2026 | $98.72 |
| Sep 4, 2026 | $97.64 |
| Sep 8, 2026 | $94.89 |
| Sep 9, 2026 | $94.60 |
| Sep 10, 2026 | $93.03 |
| Sep 11, 2026 | $92.91 |
| Sep 14, 2026 | $93.64 |
| Sep 15, 2026 | $93.11 |
| Sep 16, 2026 | $93.37 |
| Sep 17, 2026 | $95.67 |
| Sep 18, 2026 | $94.91 |
| Sep 21, 2026 | $95.97 |
| Sep 22, 2026 | $97.67 |
| Sep 23, 2026 | $96.27 |
| Sep 24, 2026 | $97.23 |
| Sep 25, 2026 | $97.26 |
| Sep 28, 2026 | $97.29 |
| Sep 29, 2026 | $97.16 |
| Sep 30, 2026 | $97.29 |
| Oct 1, 2026 | $95.10 |
| Oct 2, 2026 | $95.07 |
| Oct 5, 2026 | $97.04 |
| Oct 6, 2026 | $94.70 |
| Oct 7, 2026 | $94.83 |
| Oct 8, 2026 | $94.25 |
| Oct 9, 2026 | $96.90 |
| Oct 12, 2026 | $96.44 |
| Oct 13, 2026 | $94.94 |
| Oct 14, 2026 | $96.72 |
| Oct 15, 2026 | $98.65 |
| Oct 16, 2026 | $96.08 |
| Oct 19, 2026 | $96.71 |
| Oct 20, 2026 | $99.22 |
| Oct 21, 2026 | $99.56 |
| Oct 22, 2026 | $99.38 |
| Oct 23, 2026 | $98.72 |
| Oct 26, 2026 | $99.21 |
| Oct 27, 2026 | $100.74 |
| Oct 28, 2026 | $101.87 |
| Oct 29, 2026 | $103.46 |
| Oct 30, 2026 | $102.50 |
| Nov 2, 2026 | $101.13 |
| Nov 3, 2026 | $102.34 |
| Nov 4, 2026 | $104.67 |
| Nov 5, 2026 | $99.20 |
| Nov 6, 2026 | $99.03 |
| Nov 9, 2026 | $100.84 |
| Nov 10, 2026 | $99.62 |
| Nov 11, 2026 | $100.27 |
| Nov 12, 2026 | $98.43 |
| Nov 13, 2026 | $97.88 |
| Nov 16, 2026 | $95.82 |
Weekly net flows, 3M
Net inflow over the range: +$39M
- Inflow / above zero
- Outflow / below zero
Show as table
| Label | Value ($) |
|---|---|
| Aug 10 | $4.7M |
| Aug 17 | $3.9M |
| Aug 24 | $2M |
| Aug 31 | $18.3M |
| Sep 7 | $1.9M |
| Sep 14 | $0 |
| Sep 21 | $0 |
| Sep 28 | $952.1K |
| Oct 5 | −$1.9M |
| Oct 12 | −$966.1K |
| Oct 19 | $981.4K |
| Oct 26 | −$4.1M |
| Nov 2 | $3M |
| Nov 9 | $10M |
Money keeps arriving — +$10M of net inflows over the past month, about 2.3% of the fund's asset base, while the price has returned +16.6% so far this year. At 0.59% a year it is not the cheapest way in — IWM has a reported fee of 0.19%.
COMPOSED FROM THE FUND’S OWN DAILY RECORDS · UPDATED WITH EACH REFRESH
CELL SIZE IS PORTFOLIO WEIGHT · COLOR IS THE CHANGE IN THE LATEST AVAILABLE SNAPSHOT · TOP 40 POSITIONS
| # | Holding | Weight | Price | Day | 52-wk | |
|---|---|---|---|---|---|---|
| 1 | REGNREGENERON PHARMACEUTICALS | 5.78% | $952.40 | -0.3% | ||
| 2 | BIIBBIOGEN | 5.78% | $251.65 | -0.7% | ||
| 3 | GILDGILEAD SCIENCES | 5.69% | $167.58 | -0.3% | ||
| 4 | RPRXROYALTY PHARMA | 5.63% | $68.53 | -1.1% | ||
| 5 | AMGNAMGEN | 5.31% | $462.32 | -0.7% | ||
| 6 | VRTXVERTEX PHARMACEUTICALS | 4.91% | $537.79 | -0.2% | ||
| 7 | ILMNILLUMINA | 4.64% | $198.00 | -4.4% | ||
| 8 | NTRANATERA | 4.78% | $288.48 | -9.6% | ||
| 9 | MRNAMODERNA | 3.87% | $215.27 | -3.6% | ||
| 10 | VCELVERICEL | 3.62% | $57.48 | +0.9% | ||
| 11 | EXELEXELIXIS | 3.34% | $67.10 | -2.8% | ||
| 12 | QGENQIAGEN NV | 3.14% | $49.81 | -0.2% | ||
| 13 | UTHRUNITED THERAPEUTICS | 3.13% | $587.88 | -0.6% | ||
| 14 | TGTXTG THERAPEUTICS | 3.20% | $62.76 | -2.7% | ||
| 15 | NBIXNEUROCRINE BIOSCIENCES | 3.00% | $165.31 | -1.2% |
The full book, free with one sign-in.
Top 15 positions are open to everyone. Sign in once and every fund’s complete holdings — plus watchlists and flow alerts — unlock across the network.
Sign in to see all 31Sector weights
- Healthcare100%
- Health Technology91.43%
- Health Services8.5%
- Other0.1%
- Mutual fund0.08%
Show as table
| Item | Value (%) |
|---|---|
| Healthcare | 100% |
| Health Technology | 91.43% |
| Health Services | 8.5% |
| Other | 0.1% |
| Mutual fund | 0.08% |
Country weights
- United States100%
- Ireland3.05%
- Netherlands2.73%
- Canada2.43%
Show as table
| Item | Value (%) |
|---|---|
| United States | 100% |
| Ireland | 3.05% |
| Netherlands | 2.73% |
| Canada | 2.43% |
| 1 week | -3.8% |
| 1 month | -0.3% |
| 3 months | +2.2% |
| 6 months | +18.5% |
| YTD | +16.6% |
| 1 year | — |
| 3 years | — |
PRICE RETURN, DISTRIBUTIONS NOT REINVESTED
| 1 week | +$5M |
| 1 month | +$10M |
| 3 months | +$34M |
| YTD | +$122M |
| 1 year | +$122M |
CREATION/REDEMPTION DOLLARS, DAILY RECORDS
Monthly net flows
- Inflow / above zero
- Outflow / below zero
Show as table
| Label | Value ($) |
|---|---|
| Sep | −$3.5M |
| Oct | $0 |
| Feb | $3.2M |
| Mar | −$5.4M |
| Apr | $31.2K |
| May | −$1.6M |
| Jun | $1.7M |
| Jul | $4.6M |
| Aug | $161.4M |
| Sep | −$50.1M |
| Oct | −$5.1M |
| Nov | $13M |
The top holding is 5.8% of the book; the top ten carry 50%. Spread across 34+ names, it behaves like roughly 26 equally-weighted positions.
VOLATILITY & DRAWDOWN FROM THE DAILY TAPE · CONCENTRATION FROM THE LATEST DISCLOSED BOOK
| Most-traded holdings, options premium | Bullish | Bearish |
|---|---|---|
| MRNA MODERNA | $30M | $26M |
| NTRA NATERA | $20M | $1M |
| REGN REGENERON PHARMACEUTICALS | $4M | $2M |
| AMGN AMGEN | $3M | $3M |
| GILD GILEAD SCIENCES | $2M | $2M |
TODAY’S OPTIONS PREMIUM IN THE FUND’S UNDERLYING NAMES
Due diligence cuts both ways. These funds sit on the same shelf and beat PBE on at least one dimension that matters — the fee, the asset base, or where the money is going.
| Fund | Fee | Assets | Flow, 1M | The case | |
|---|---|---|---|---|---|
| IVV iShares Core S&P 500 ETF | 0.03% | $879.1B | +$10.1B | -56bp on fee · 2024× the assets · +$10.1B in over the month | Head-to-head |
| SPDW SPDR Portfolio Developed World ex-US ETF | 0.03% | $41.6B | +$917M | -56bp on fee · 96× the assets · +$917M in over the month | Head-to-head |
| BBUS JPMorgan BetaBuilders U.S. Equity ETF | 0.02% | $9.7B | +$356M | -57bp on fee · 22× the assets · +$356M in over the month | Head-to-head |
| SPMD State Street SPDR Portfolio S&P 400 Mid Cap ETF | 0.03% | $18.4B | +$199M | -56bp on fee · 42× the assets · +$199M in over the month | Head-to-head |
| SPTM State Street SPDR Portfolio S&P 1500 Composite Stock Market ETF | 0.03% | $14.2B | +$235M | -56bp on fee · 33× the assets · +$235M in over the month | Head-to-head |


